(1)
Frésard, I.; Bridevaux, P.; Janssens, J. Adverse Effects and Adherence to Treatment of Rifampicin 4 months Vs Isoniazid 6 months for Latent Tuberculosis. Swiss Med Wkly 2011, 141, w13240.